Lack of microRNA miR-150 reduces the capacity of epidermal Langerhans cell cross-presentationMI, Qing-Sheng; XU, Ying-Ping; QI, Rui-Qun et al.Experimental dermatology. 2012, Vol 21, Num 11, pp 876-878, issn 0906-6705, 3 p.Article

Uncommon histiocytic disorders : The non-langerhans cell histiocytosesWEITZMAN, Sheila; JAFFE, Ronald.Pediatric blood & cancer. 2005, Vol 45, Num 3, pp 256-264, issn 1545-5009, 9 p.Article

Langerhans cell histiocytosis: a case study suggesting a reactive aetiologyLE FOURN, E; MARUANI, A; DE MURET, A et al.British journal of dermatology (1951). 2010, Vol 163, Num 1, pp 210-211, issn 0007-0963, 2 p.Article

Telomere length shortening in Langerhans cell histiocytosisBECHAN, Gitanjali I; MEEKER, Alan K; DE MARZO, Angelo M et al.British journal of haematology. 2008, Vol 140, Num 4, pp 420-428, issn 0007-1048, 9 p.Article

Gene expression analysis of dendritic/Langerhans cells and Langerhans cell histiocytosisRUST, R; KLUIVER, J; VISSER, L et al.Journal of pathology. 2006, Vol 209, Num 4, pp 474-483, issn 0022-3417, 10 p.Article

Differences in telomerase expression by the CD1a⁺ cells in Langerhans cell histiocytosis reflect the diverse clinical presentation of the diseaseDA COSTA, C. E. T; EGELER, R. M; HOOGEBOOM, M et al.Journal of pathology. 2007, Vol 212, Num 2, pp 188-197, issn 0022-3417, 10 p.Article

Urocanic acid suppresses induction of immunity in human skinDAHL, Mark V; MCEWEN, Gerald N; IRVING KATZ, H et al.Photodermatology photoimmunology & photomedicine. 2010, Vol 26, Num 6, pp 303-310, issn 0905-4383, 8 p.Article

PEROXIDATIC ACTIVITY IN ENDOPLASMIC RETICULUM OF NORMAL HUMAN LANGERHANS CELLSDUBERTRET L; BRETON GORIUS J; FOSSE M et al.1981; J. RETICULOENDOTHEL. SOC.; ISSN 0033-6890; USA; DA. 1981; VOL. 30; NO 4; PP. 313-316; BIBL. 14 REF.Article

Primary langerhans cell histiocytosis of the vulvaVENIZELOS, Ioannis D; MANDALA, Eudokia; TATSIOU, Zoi A et al.International journal of gynecological pathology. 2006, Vol 25, Num 1, pp 48-51, issn 0277-1691, 4 p.Article

Development of an ex vivo human skin model for intradermal vaccination: Tissue viability and Langerhans cell behaviourKENG WOOI NG; PEARTON, Marc; COULMAN, Sion et al.Vaccine. 2009, Vol 27, Num 43, pp 5948-5955, issn 0264-410X, 8 p.Article

Histiocitosis de células de Langerhans = Langerhans cell histiocytosisVALDIVIELSO, Marta; BUENO, Celso.Actas dermo-sifiliográficas (Ed. impresa). 2005, Vol 96, Num 5, pp 275-284, issn 0001-7310, 10 p.Article

Langerhans cell histiocytosis in a 5-month-old presenting with biparietal masses: Case reportPRICOLA, Katie L; KARAMCHANDANI, Jason; VOGEL, Hannes et al.Journal of neurosurgery. Pediatrics. 2010, Vol 6, Num 4, pp 393-397, issn 1933-0707, 5 p.Article

Pulmonary Langerhans' cell histiocytosis presenting with an endobronchial lesionSUZUKI, Masaru; BETSUYAKU, Tomoko; SUGA, Masayuki et al.Internal medicine (Tokyo. 1992). 2004, Vol 43, Num 3, pp 227-230, issn 0918-2918, 4 p.Article

Langerhans cell histiocytosis: Historical perspectivesLAMPERT, F.Hematology/oncology clinics of North America. 1998, Vol 12, Num 2, issn 0889-8588, vii,213-219 [8 p.]Article

Traitement des formes sévères d'histiocytose langerhansienne = Treatment of severe Langerhans cell histiocytosisBERTRAND, Y.Pédiatrie (Marseille). 1993, Vol 48, Num 11, pp 770-774, issn 0031-4021Article

Oral Langerhans cell histiocytosis: Antigen-Ki-67 as a indicator for local tumor behaviourBARTNICK, Arnd; FRIEDRICH, Reinhard E; ROESER, Kerstin et al.Anticancer research. 2003, Vol 23, Num 2A, pp 921-926, issn 0250-7005, 6 p.Conference Paper

Langerhans cells in connective tissue diseasesGOOBAR, J. P; FANG, M; WEISMAN, M. H et al.Scandinavian journal of rheumatology. 1987, Vol 16, Num 4, pp 273-279, issn 0300-9742Article

Lesions resembling langerhans cell histiocytosis in association with other lymphoproliferative disorders : a reactive or neoplastic phenomenon?CHRISTIE, Lesley J; EVANS, Alan T; BRAY, Susan E et al.Human pathology. 2006, Vol 37, Num 1, pp 32-39, issn 0046-8177, 8 p.Article

Specific polymorphisms of cytokine genes are associated with different risks to develop single-system or multi-system childhood Langerhans cell histiocytosisDE FILIPPI, Paola; BADULLI, Carla; DANESINO, Cesare et al.British journal of haematology. 2006, Vol 132, Num 6, pp 784-787, issn 0007-1048, 4 p.Article

Epidermal Langerhans cells. A cycling cell populationCZERNIELEWSKI, J; VAIGOT, P; PRUNIERAS, M et al.Journal of investigative dermatology. 1985, Vol 84, Num 5, pp 424-426, issn 0022-202XArticle

Immunological and histochemical analysis of regional variations of epidermal Langerhans cells in normal human skinTHOMAS, J. A; BIGGERSTAFF, M; SLOANE, J. P et al.Histochemical journal. 1984, Vol 16, Num 5, pp 507-519, issn 0018-2214Article

LACK OF LYSOZYME, ALPHA ₁-ANTITRYPSIN AND ALPHA ₁-ANTICHYMOTRYPSIN IN NORMAL LANGERHANS CELLS: DIFFERENTIATION FROM CELLS OF THE MONOCYTE-HISTIOCYTE-MACROPHAGE SERIESHOLDEN CA; KERDEL FA; MACDONALD DM et al.1982; ACTA DERMATO-VENEREOLOGICA; ISSN 0001-5555; SWE; DA. 1982; VOL. 62; NO 6; PP. 513-514; BIBL. 14 REF.Article

IMMUNOHISTOCHEMICAL CHARACTERIZATION OF RENIN-CONTAINING CELLS IN THE HUMAN JUXTAGLOMERULAR APPARATUS DURING EMBRYONAL AND FETAL DEVELOPMENTPHAT VN; CAMILLERI JP; BARIETY J et al.1981; LAB. INVEST.; ISSN 0023-6837; USA; DA. 1981; VOL. 45; NO 5; PP. 387-390; BIBL. 22 REF.Article

IL-Iβ and PGE₂ levels are increased in the saliva of children with Langerhans cell histiocytosisPRELIASCO, Virginia F; BENCHUYA, Carolina; PAVAN, Veronica et al.Journal of oral pathology & medicine. 2008, Vol 37, Num 9, pp 522-527, issn 0904-2512, 6 p.Article

Immunohistochemical Expression of Langerin in Langerhans Cell Histiocytosis and Non-Langerhans Cell Histiocytic DisordersLAU, Sean K; CHU, Peiguo G; WEISS, Lawrence M et al.The American journal of surgical pathology. 2008, Vol 32, Num 4, pp 615-619, issn 0147-5185, 5 p.Article